Form 4: Pressure BioSciences Director Acquires Shares as Interest Payment

Director Alexander V. Lazarev acquired 18,863 shares of Pressure BioSciences Inc. as interest on convertible preferred stock.

Summary

• On September 27, 2024, Alexander V. Lazarev, a director of Pressure BioSciences Inc., acquired 18,863 shares of common stock.
• The shares were acquired as interest on convertible preferred stock at a price of $0.028 per share.
• Following the transaction, Lazarev directly owns 37,400 shares of Pressure BioSciences Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The director increasing their holdings could be seen as slightly positive, but it's a small transaction related to interest payment.

Positives

• Director Lazarev increased his stake in the company, which could be interpreted as a sign of confidence.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be informative for investors.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects a director's increased stake in the company.

Key Dates

Keywords

Pressure BioSciences Inc, PBIO, Alexander V. Lazarev, Director, Share Acquisition, Convertible Preferred Stock, Interest Payment, Form 4, SEC